Ownership history in Commodore Capital LP · 9 quarters on record
This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in PROTAGONIST THERAPEUTICS INC (PTGX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 450,000 | -575,000 | -56.1% | 2.62% | $39.3M | $87.34 |
| 2025 Q3 | REDUCED | 1,025,000 | -50,000 | -4.7% | 3.32% | $68.1M | $66.43 |
| 2025 Q2 | ADDED | 1,075,000 | +743,114 | +223.9% | 4.19% | $59.4M | $55.27 |
| 2022 Q1 | REDUCED | 331,886 | -473,687 | -58.8% | 1.76% | $7.9M | $23.68 |
As of 2025 Q4 — sorted by position size